Article
Kinesin spindle protein inhibitors in cancer: a patent review (2008 - present).
Expert opinion on therapeutic patents - 1 Dec 2013
Jiang Cheng, You Qidong
Abstract excerpt
INTRODUCTION: Inhibition of kinesin spindle protein (KSP) has emerged as a novel and validated therapeutic strategy against cancers. A lot of new KSP inhibitors have been identified in recent years and some of them have entered clinical trials. This may provide more selections in future cancer therapy. AREAS COVERED: In the present review, the authors will describe the most recent classes of KSP inhibitors by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
